Skip to main content
Erschienen in: European Journal of Pediatrics 7/2005

01.07.2005 | Original Paper

The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance

verfasst von: In Kyoung Choi, Duk Hee Kim, Ho-Seong Kim

Erschienen in: European Journal of Pediatrics | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Abstract

An oral glucose tolerance test (OGTT) was performed in 103 patients with Turner syndrome (TS) who had normal fasting and postprandial glucose levels. The plasma glucose, insulin, C-peptide and proinsulin levels were measured every 30 min during the test. Using a homeostatic model assessment (HOMA) and a quantitative insulin sensitivity check index (QUICKI), the insulin resistance in TS patients was investigated. Diabetes mellitus and impaired glucose tolerance (IGT) were newly diagnosed in two and 18 patients respectively. There was a significant increase in mean plasma glucose, insulin, C-peptide and proinsulin reponse during an OGTT in the IGT group in contrast to the normal glucose tolerance (NGT) group ( P <0.05). There was a significant decrease in the quantitative insulin sensitivity check index (QUICKI) in the IGT group in contrast to the NGT group ( P <0.05). The fasting insulin and triglyceride levels strongly predicted the 2 h glucose level during the OGTT ( P <0.05). Conclusion:The oral glucose tolerance test is superior to the fasting and postprandial plasma glucose test for the early detection of abnormalities of carbohydrate metabolism in patients with Turner syndrome.
Literatur
1.
Zurück zum Zitat Andres R, Swerdloff R, Pozefsky T, Coleman D (1966) Manual feedback techniques for control of glucose concentration. In: Skeegs LT (ed) Automation in analytic chemistry. Medaid, New York, pp 486–491 Andres R, Swerdloff R, Pozefsky T, Coleman D (1966) Manual feedback techniques for control of glucose concentration. In: Skeegs LT (ed) Automation in analytic chemistry. Medaid, New York, pp 486–491
2.
Zurück zum Zitat Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA (2004) Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89: 3516–3520 Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA (2004) Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89: 3516–3520
3.
Zurück zum Zitat Bergman RN (1989) Lilly Lecture 1989. Towards physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512–1527 Bergman RN (1989) Lilly Lecture 1989. Towards physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512–1527
4.
Zurück zum Zitat Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45–86 Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45–86
5.
Zurück zum Zitat Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the isulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790–800 Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the isulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790–800
6.
Zurück zum Zitat Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV (1991) Insulin resistance:an early metabolic defect of Tuener’s syndrome. J Clin Endocrinol Metab 72: 832–836 Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV (1991) Insulin resistance:an early metabolic defect of Tuener’s syndrome. J Clin Endocrinol Metab 72: 832–836
7.
Zurück zum Zitat Caprio S, Boulware S, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, Tamborlane WV (1992) Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 120: 238–243 Caprio S, Boulware S, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, Tamborlane WV (1992) Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 120: 238–243
8.
Zurück zum Zitat Cicognani A, Mazzanti L, Tassinari D, Pellacanti A, Forabosco A, Land L (1988) Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Pediatrics 12: 1072–1080 Cicognani A, Mazzanti L, Tassinari D, Pellacanti A, Forabosco A, Land L (1988) Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Pediatrics 12: 1072–1080
9.
Zurück zum Zitat Davis SN, Monti L, Piatti PM, Moller N, Ng L, Coppack S, May M, Brown MD, Orskov H, Alberti KG (1993) Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res 23: 1–18 Davis SN, Monti L, Piatti PM, Moller N, Ng L, Coppack S, May M, Brown MD, Orskov H, Alberti KG (1993) Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res 23: 1–18
10.
Zurück zum Zitat DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177–269 DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177–269
11.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–E223 DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–E223
12.
Zurück zum Zitat Fagot-Compagna A, Saadine J, Flegal KM, Beckles GL (2001) Diabetes, impaired fasting glucose and elevated HBA1c in US adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 24[Suppl 5]: S134–S137 Fagot-Compagna A, Saadine J, Flegal KM, Beckles GL (2001) Diabetes, impaired fasting glucose and elevated HBA1c in US adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 24[Suppl 5]: S134–S137
13.
Zurück zum Zitat Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19: 491–503 Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19: 491–503
14.
Zurück zum Zitat Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51: 147–158 Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51: 147–158
15.
Zurück zum Zitat Haffner SM, Gonzalez C, Mykkänen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40: 830–837 Haffner SM, Gonzalez C, Mykkänen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40: 830–837
16.
Zurück zum Zitat Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L (2002) Detection of insulin resistance by simple quantitative insulin check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87: 144–147 Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L (2002) Detection of insulin resistance by simple quantitative insulin check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87: 144–147
17.
Zurück zum Zitat Karp M, Sniz A, Dozon M (1975) Glucose tolerance tests and insulin response in juvenile patients with gonadal dysgenesis. Mod Probl Paediatr 12: 251–257 Karp M, Sniz A, Dozon M (1975) Glucose tolerance tests and insulin response in juvenile patients with gonadal dysgenesis. Mod Probl Paediatr 12: 251–257
18.
Zurück zum Zitat Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y (2002) QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 87: 2906–2908 Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y (2002) QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 87: 2906–2908
19.
Zurück zum Zitat Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402–2410 Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402–2410
20.
Zurück zum Zitat Lippe B, Rosenfeld RG, Hintz RL, Johanson AJ, Frane J, Sherman B (1988) Treatment of Turner syndrome with recombinant human growth hormone (somatrem). Acta Pediatr Scand 343: 47–52 Lippe B, Rosenfeld RG, Hintz RL, Johanson AJ, Frane J, Sherman B (1988) Treatment of Turner syndrome with recombinant human growth hormone (somatrem). Acta Pediatr Scand 343: 47–52
21.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 23: 412–419 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 23: 412–419
22.
Zurück zum Zitat Mykkänen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laasko M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38: 1176–1182 Mykkänen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laasko M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38: 1176–1182
23.
Zurück zum Zitat Naeraa RW, Gravholt CH, Hansen J, Nielsen J, Juul S (1995) Mortality in Turner syndrome. In: Albertsson-Wikland K, Ranke MB (eds) Turner syndrome in a life span perspective: research and clinical aspects. Elsevier, Amsterdam, pp 323 Naeraa RW, Gravholt CH, Hansen J, Nielsen J, Juul S (1995) Mortality in Turner syndrome. In: Albertsson-Wikland K, Ranke MB (eds) Turner syndrome in a life span perspective: research and clinical aspects. Elsevier, Amsterdam, pp 323
24.
Zurück zum Zitat Neufeld ND, Lippe B, Sperling MA (1976) Carbohydrate intolerance in gonadal dysgenesis: a new model of insulin resistance. Diabetes 25: 379 Neufeld ND, Lippe B, Sperling MA (1976) Carbohydrate intolerance in gonadal dysgenesis: a new model of insulin resistance. Diabetes 25: 379
25.
Zurück zum Zitat Nielsen J, Johansen K, Yde H (1969) The frequency of diabetes mellitus in patients with Turner’s syndrome and pure gonadal dysgenesis:blood glucose, plasma insulin and growth hormone level during an oral glucose tolerance test. Acta Endocrinol Copenh 62: 251–269 Nielsen J, Johansen K, Yde H (1969) The frequency of diabetes mellitus in patients with Turner’s syndrome and pure gonadal dysgenesis:blood glucose, plasma insulin and growth hormone level during an oral glucose tolerance test. Acta Endocrinol Copenh 62: 251–269
26.
Zurück zum Zitat Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn study. Diabetologia 39: 113–118 Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ (1996) Fasting proinsulin and 2-h post load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn study. Diabetologia 39: 113–118
27.
Zurück zum Zitat Pareren YK, Muinck Keizer-Schrama SMPF, Stijnen T, Drop SLS, The Dutch Advisory Group on Growth Hormone (2002) Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 87: 5442–5448 Pareren YK, Muinck Keizer-Schrama SMPF, Stijnen T, Drop SLS, The Dutch Advisory Group on Growth Hormone (2002) Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 87: 5442–5448
28.
Zurück zum Zitat Polychronakos C, Letarte J, Collu R, Ducharme JR (1980) Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 96: 1009–1014 Polychronakos C, Letarte J, Collu R, Ducharme JR (1980) Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 96: 1009–1014
29.
Zurück zum Zitat Rasio E, Antaki A, Van Campenhout J (1976) Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion. Eur J Clin Invest 6: 59–66 Rasio E, Antaki A, Van Campenhout J (1976) Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion. Eur J Clin Invest 6: 59–66
30.
Zurück zum Zitat Roder ME, Porte D, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired β-cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 83: 604–608 Roder ME, Porte D, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired β-cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 83: 604–608
31.
Zurück zum Zitat Saad MF, Steil GM, Kades WW (1997) Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46: 1167–1171 Saad MF, Steil GM, Kades WW (1997) Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46: 1167–1171
32.
Zurück zum Zitat Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802–810 Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802–810
33.
Zurück zum Zitat Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G (1990) Characteristics of insulin resistance in Turner syndrome. Diabetes Metab 16: 267–271 Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G (1990) Characteristics of insulin resistance in Turner syndrome. Diabetes Metab 16: 267–271
34.
Zurück zum Zitat The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (1999) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22[Suppl 1]: S5–S19 The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (1999) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22[Suppl 1]: S5–S19
35.
Zurück zum Zitat Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22: 262–270 Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22: 262–270
36.
Zurück zum Zitat Wilson DM, Frane JW, Sherman B (1988) Turner syndrome: effect of therapy with with growth hormone, oxandrolone, and a combination of both. J Pediatr 112: 210–217 Wilson DM, Frane JW, Sherman B (1988) Turner syndrome: effect of therapy with with growth hormone, oxandrolone, and a combination of both. J Pediatr 112: 210–217
Metadaten
Titel
The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance
verfasst von
In Kyoung Choi
Duk Hee Kim
Ho-Seong Kim
Publikationsdatum
01.07.2005
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 7/2005
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-005-1643-x

Weitere Artikel der Ausgabe 7/2005

European Journal of Pediatrics 7/2005 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.